<\/p>\n
Udimax 300<\/strong> is ursodeoxycholic acid (UDCA) 300 mg<\/strong> — a hydrophilic bile acid that is the standard of care for primary biliary cholangitis (PBC), cholesterol gallstones in patients unfit for surgery, intrahepatic cholestasis of pregnancy (ICP), bile-acid diarrhoea, and pruritus of cholestatic liver disease<\/strong>. UDCA reduces cholesterol saturation in bile, replaces toxic hydrophobic bile acids in the bile-acid pool, exerts cytoprotective and anti-apoptotic effects on hepatocytes and cholangiocytes, and stimulates bicarbonate-rich choleresis. Standard adult doses range from 10–15 mg\/kg\/day for PBC and gallstones to 14–30 mg\/kg\/day for cholestasis of pregnancy<\/strong>. WHO-GMP min\u0151s\u00edt\u00e9s\u0171 gy\u00e1rt\u00f3.<\/p>\n<\/div>\n \ud83d\udce6 Minden rendel\u00e9st fedez a \u00dajrak\u00fcld\u00e9si Garancia<\/strong><\/a> \u2014 ha a csomagod nem \u00e9rkezik meg 20 munkanapon bel\u00fcl, \u00fajrak\u00fcldj\u00fck.<\/p>\n Generikus gy\u00f3gyszereink WHO-GMP min\u0151s\u00edt\u00e9s\u0171 gy\u00e1rt\u00f3kt\u00f3l sz\u00e1rmaznak, \u00e9s diszkr\u00e9t, egyszer\u0171 csomagol\u00e1sban sz\u00e1ll\u00edtjuk \u0151ket vil\u00e1gszerte \u2014 a csomagon nem szerepel a gy\u00f3gyszer neve. A k\u00e1rty\u00e1s fizet\u00e9sek egy szab\u00e1lyozott feldolgoz\u00f3n kereszt\u00fcl t\u00f6rt\u00e9nnek (a sz\u00e1mlale\u00edr\u00e1sok egy szab\u00e1lyozott k\u00e1rtyafizet\u00e9si feldolgoz\u00f3t tartalmaznak \u2014 soha nem \u201cMedsBase\u201d vagy b\u00e1rmilyen gy\u00f3gyszer neve). Kriptovalut\u00e1t \u00e9s SEPA banki \u00e1tutal\u00e1st is elfogadunk. Minden rendel\u00e9st a Reshipment Assurance Policy biztos\u00edt\u00e9k fedez.<\/p>\n Udimax 300 is supplied from a WHO-GMP tan\u00fas\u00edtott gy\u00e1rt\u00f3<\/strong>. WHO-GMP min\u0151s\u00edt\u00e9s\u0171 gy\u00e1rt\u00f3t\u00f3l sz\u00e1rmazik. Minden rendel\u00e9st diszkr\u00e9ten sz\u00e1ll\u00edtunk vil\u00e1gszerte, \u00e9s \u00dajrak\u00fcld\u00e9si Garancia<\/a> — if it does not arrive within 20 business days, we reship at no cost. UDCA has been on the WHO Essential Medicines List for decades and is the cornerstone of medical therapy for cholestatic liver disease.<\/p>\n UDCA is a naturally occurring hydrophilic 7β-hydroxy bile acid (“the bear bile acid”). When taken orally it enriches the bile-acid pool, replacing toxic hydrophobic acids (chenodeoxycholic, lithocholic) that damage cholangiocytes and hepatocytes in cholestasis. Three actions matter clinically: (1) it reduces biliary cholesterol saturation, dissolving cholesterol gallstones over months; (2) it exerts direct cytoprotective and anti-apoptotic effects on liver cells, reducing immune-mediated damage in PBC; (3) it stimulates a bicarbonate-rich “alkaline tide” choleresis, which protects cholangiocytes from the detergent action of hydrophobic bile acids. Onset of biochemical improvement in PBC is typically 2–6 months.<\/p>\nMi\u00e9rt rendelj a MedsBase-r\u00f3l<\/h3>\n
Mi\u00e9rt rendelj a MedsBase-r\u00f3l<\/h3>\n
\u2014 ha 20 munkanapon bel\u00fcl nem \u00e9rkezik meg, ingyenesen \u00fajrak\u00fcldj\u00fck. Ez az egyetlen h\u00e1ny\u00e1sg\u00e1tl\u00f3 kombin\u00e1ci\u00f3, amely FDA A kateg\u00f3ri\u00e1j\u00fa st\u00e1tusszal rendelkezik a terhess\u00e9g alatt, \u00e9s az ACOG, a NICE \u00e9s a SOGC els\u0151vonalbeli aj\u00e1nl\u00e1sa a terhess\u00e9gi h\u00e1nyinger \u00e9s h\u00e1ny\u00e1s kezel\u00e9s\u00e9re.<\/h2>\n
Indications & doses<\/h2>\n